NCT06855095 2025-03-03
ATSA
The Netherlands Cancer Institute
Phase 2/3 Recruiting
Clinical Trials
5 trialsNCT02795858 2025-02-19
A Phase II Study of Ramucirumab With Somatostatin Analog Therapy in Patients With Advanced, Progressive Carcinoid Tumors
Dana-Farber Cancer Institute
Phase 2 Completed
NCT05701241 2024-06-14
SAUNA
University Hospital, Antwerp
Phase 4 Recruiting
NCT04129255 2020-09-10
CSMS99
National Cancer Institute, Naples
Phase 2 Completed
NCT01755182 2016-05-06
LOTUS
National Cancer Institute, Naples
Phase 3 Terminated